MetaVia announces preclinical findings for DA-1726 waist reduction
MetaVia said preclinical findings support the biological rationale for DA-1726 reducing waist circumference.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.